Real-time bioluminescence and tomographic imaging of gastric cancer in a novel orthotopic mouse model

Oncology Reports

Volumn 27, Issue 6, 2012, Pages 1937-1943

  Hu, Hao ^a   Liu, Junting ^b   Yao, Liping ^a   Yin, Jipeng ^a   Su, Ning ^a   Liu, Xiangqiang ^a   Cao, Feng ^a   Liang, Jimin ^b   Nie, Yongzhan ^a   Wu, Kaichun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b XIDIAN UNIVERSITY   (China)

Author keywords

Bioluminescence imaging; Bioluminescence tomography; Drug efficacy evaluation; Orthotopic implantation; Preclinical cancer model; Three dimensional reconstruction

Indexed keywords

DOCETAXEL; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CANCER CELL CULTURE; CELL COUNT; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FLUORESCENCE IMAGING; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEREOSCOPIC VISION; STOMACH CANCER; THREE DIMENSIONAL IMAGING; TUMOR GROWTH; TUMOR MODEL; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; LUCIFERASES; LUMINESCENT MEASUREMENTS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR IMAGING; STOMACH NEOPLASMS;

EID: 84860712949     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1713     Document Type: Article

References (41)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. De Vita F, Giuliani F, Galizia G, et al: Neo-adjuvant and adjuvant chemotherapy of gastric cancer. Ann Oncol 18 (Suppl 6): vi120-vi123, 2007.
3. Welsh DK and Kay SA: Bioluminescence imaging in living organisms. Curr Opin Biotechnol 16: 73-78, 2005. (Pubitemid 40249761)
4. Weissleder R and Pittet MJ: Imaging in the era of molecular oncology. Nature 452: 580-589, 2008. (Pubitemid 351483372)
5. Buchhorn HM, Seidl C, Beck R, et al: Non-invasive visualisation of the development of peritoneal carcinomatosis and tumour regression after Bi-213-radioimmunotherapy using biolumin-escence imaging. Eur J Nucl Med Mol Imaging 34: 841-849, 2007. (Pubitemid 46798953)
6. Zhao H, Doyle TC, Coquoz O, Kalish F, Rice BW and Contag CH: Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J Biomed Opt 10: 41210, 2005.
7. Angst E, Chen M, Mojadidi M, Hines OJ, Reber HA and Eibl G: Bioluminescence imaging of angiogenesis in a murine orthotopic pancreatic cancer model. Mol Imaging Biol 12: 570-575, 2010.
8. Snoeks TJA, Lowik C and Kaijzel EL: 'In vivo' optical approaches to angiogenesis imaging. Angiogenesis 13: 135-147, 2010.
9. Jenkins DE, Oei Y, Hornig YS, et al: Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 20: 733-744, 2003. (Pubitemid 38019275)
10. Chen L, Yang S, Jakoncic J, Zhang JJ and Huang X-Y: Migrastatin analogues target fascin to block tumour metastasis. Nature 464: 1062-1135, 2010.
11. Pichler A, Zelcer N, Prior JL, Kuil AJ and Piwnica-Worm D: In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein. Clin Cancer Res 11: 4487-4494, 2005. (Pubitemid 40825639)
12. Hajitou A, Trepel M, Lilley CE, et al: A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell 125: 385-398, 2006.
13. Zeamari S, Rumping G, Floot B, Lyons S and Stewart FA: In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats. Br J Cancer 90: 1259-1264, 2004. (Pubitemid 38496822)
14. Edinger M, Cao YA, Verneris MR, Bachmann MH, Contag CH and Negrin RS: Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 101: 640-648, 2003. (Pubitemid 36077588)
15. Paroo Z, Bollinger RA, Braasch DA, et al: Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol Imaging 3: 117-124, 2004.
16. Wilmanns C, Fan D, Obrian CA, Bucana CD and Fidler IJ: Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int J Cancer 52: 98-104, 1992.
17. Killion JJ, Radinsky R and Fidler IJ: Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 17: 279-284, 1998. (Pubitemid 29210167)
18. Hoffman RM: Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17: 343-359, 1999.
19. Bibby MC: Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer 40: 852-857, 2004.
20. McCarty MF, Takeda A, Stoeltzing O, et al: ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer. Br J Cancer 90: 705-711, 2004. (Pubitemid 38297214)
21. Nakajima TE, Yanagihara K, Takigahira M, et al: Antitumor effect of SN-38-releasing polymeric micelles, NK012, on spontaneous peritoneal metastases from orthotopic gastric cancer in mice compared with irinotecan. Cancer Res 68: 9318-9322, 2008.
22. Sumida T, Kitadai Y, Shinagawa K, et al: Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model. Int J Cancer 128: 2050-2062, 2011.
23. Wang G, Hoffman E, McLennan G, Wang L, Suter M and Meinel J: Development of the first bioluminescent CT scanner. Radiology 229: 566, 2003.
24. Wang G, Li Y and Jiang M: Uniqueness theorems in bioluminescence tomography. Med Phys 31: 2289-2299, 2004. (Pubitemid 39079722)
25. Liu JTJ, Li X, Yang X, Chen X, Chen Y and Zhou Y: Detecting metastasis of gastric carcinoma using high-resolution micro-CT system: in vivo small animal study. Proc SPIE Medical Imaging 7965: 796501-779656, 2011.
26. Alexandrakis G, Rannou F and Chatziioannou A: Tomographic bioluminescence imaging by use of a combined optical-PET (OPET) system: a computer simulation feasibility study. Phys Med Biol 50: 4225-4242, 2005.
27. Liu J, Wang Y, Qu X, et al: In vivo quantitative bioluminescence tomography using heterogeneous and homogeneous mouse models. Opt Express 18: 13102-13113, 2010.
28. Edinger M, Cao YA, Hornig YS, et al: Advancing animal models of neoplasia through in vivo bioluminescence imaging. European Eur J Cancer 38: 2128-2136, 2002. (Pubitemid 35223250)
29. Vilalta M, Degano IR, Bago J, et al: Biodistribution, long-term survival, and safety of human adipose tissue-derived mesenchymal stem cells transplanted in nude mice by high sensitivity non-invasive bioluminescence imaging. Stem Cells Dev 17: 993-1003, 2008.
30. Bogenrieder T and Herlyn M: Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22: 6524-6536, 2003. (Pubitemid 37372332)
31. Francia G, Cruz-Munoz W, Man S, Xu P and Kerbel RS: Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat Rev Cancer 11: 135-141, 2011.
32. Fidler IJ and Balch CM: The biology of cancer metastasis and implications for therapy. Curr Probl Surg 24: 129-209, 1987.
33. Ito H, Hatori M, Kinugasa Y, Irie T, Tachikawa T and Nagumo M: Comparison of the expression profile of metastasis-associated genes between primary and circulating cancer cells in oral squamous cell carcinoma. Anticancer Res 23: 1425-1431, 2003. (Pubitemid 36754110)
34. Doubrovin M, Serganova I, Mayer-Kuckuk P, Ponomarev V and Blasberg RG: Multimodality in vivo molecular-genetic imaging. Bioconjug Chem 15: 1376-1388, 2004. (Pubitemid 39552028)
35. El-Deiry WS, Sigman CC and Kelloff GJ: Imaging and oncologic drug development. J Clin Oncol 24: 3261-3273, 2006. (Pubitemid 46628469)
36. Luker GD and Luker KE: Optical imaging: Current applications and future directions. J Nucl Med 49: 1-4, 2008.
37. Liu J, Chen D, Li X, et al: In vivo quantitative reconstruction studies of bioluminescence tomography: effects of peak-wavelength shift and model deviation. IEEE Trans Biomed Eng 57: 2579-2582, 2010.
38. Lu Y, Machado HB, Bao Q, Stout D, Herschman H and Chatziioannou AF: In vivo mouse bioluminescence tomography with radionuclide-based imaging validation. Mol Imaging Biol 13: 53-58, 2011.
39. Lv Y, Tian J, Cong W, et al: A multilevel adaptive finite element algorithm for bioluminescence tomography. Opt Express 14: 8211-8223, 2006. (Pubitemid 44331037)
40. Cong WX, Wang G, Kumar D, et al: Practical reconstruction method for bioluminescence tomography. Opt Express 13: 6756-6771, 2005.
41. Wang G, Cong W, Durairaj K, et al: In vivo mouse studies with bioluminescence tomography. Opt Express 14: 7801-7809, 2006. (Pubitemid 44277515)